Indo-Bangla Pharmaceuticals (DHA:IBP) EPS (Basic): BDT (TTM As of . 20)


DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT15.30
View Full Analysis

What is Indo-Bangla Pharmaceuticals EPS (Basic)?

Indo-Bangla Pharmaceuticals DHA:IBP +1.32% 32 EPS (Basic) is BDT as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Indo-Bangla Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in . 20 was BDT0.00. Indo-Bangla Pharmaceuticals does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Indo-Bangla Pharmaceuticals's EPS (Diluted) for the six months ended in . 20 was BDT0.00. Indo-Bangla Pharmaceuticals does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Indo-Bangla Pharmaceuticals's EPS without NRI for the six months ended in . 20 was BDT0.00. Indo-Bangla Pharmaceuticals does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Indo-Bangla Pharmaceuticals  (DHA:IBP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Indo-Bangla Pharmaceuticals EPS (Basic) Related Terms

Indo-Bangla Pharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals EPS (Basic) Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
EPS (Basic)

Indo-Bangla Pharmaceuticals Semi-Annual Data
EPS (Basic)
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Indo-Bangla Pharmaceuticals's Basic EPS for the fiscal year that ended in . 20 is calculated as

Basic EPS (A: . 20 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-)/0
=

Indo-Bangla Pharmaceuticals's Basic EPS for the quarter that ended in . 20 is calculated as

Basic EPS (Q: . 20 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-)/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of BDT mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a EPS (Basic) of BDT as of . 20. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Indo-Bangla Pharmaceuticals and its competitors.
Is Indo-Bangla Pharmaceuticals' EPS (Basic) too high?
Indo-Bangla Pharmaceuticals' current EPS (Basic) is BDT. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' EPS (Basic) compare to ?
Indo-Bangla Pharmaceuticals' EPS (Basic) of BDT can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current EPS (Basic) is BDT. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current EPS (Basic) of BDT. The current EPS (Basic) is BDT. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current EPS (Basic) is BDT as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.30
Price